Close this search box.
Close this search box.

The importance of diversity in clinical trials

In this article, Dr Harriet Gray-Stephens, Pharmaceutical Physician in the Clinical and Medical Affairs team at Boyds, discusses the importance of diversity in clinical trials and the steps that are being taken to improve the quality of data derived from clinical research.

A guide to plain language summaries (PLS)

Plain Language Summaries

In this blog, Naomi Clout, Senior Regulatory and Medical Writer at Boyds, discusses the importance of Plain Language Summaries as an effective scientific communication tool that can be easily comprehended by people who aren’t experts in the field and the steps involved in creating a PLS.

European Commission proposes extension of Medical Devices Regulation transition period in bid to prevent medical device shortages

At the Employment, Social Policy, Health and Consumer Affairs (EPSCO) meeting on 09 December 2022, the European Commissioner for Health and Safety, Stella Kyriakides, put forward proposals in her opening speech to extend the transition rules of the Medical Devices Regulation (EU) 2017/745. The Medical Devices Regulation (MDR) was adopted by the European Parliament and […]

What is a Target Product Profile and when is it needed?

When embarking on a journey it is preferable to have a destination or end goal in mind. The same is true when developing biopharmaceutical products; having an end goal or milestone to target helps keep the project team focused on what is required to reach the desired endpoint. A Target Product Profile (TPP), as the […]

Mitigating the risks with scientific due diligence

The need for scientific due diligence When companies enter into a deal, the successful outcome of that deal is subject to both parties working together to share information until an agreement can be reached. For biotech and life sciences companies, this is often achieved through scientific due diligence. Due diligence carries the simple understanding; you […]